Thomas Ciulla

Company: Ikarovec

Job title: President & Chief Executive Officer

Seminars:

Developing Dual-Acting Gene Therapy to Combat Geographic Atrophy & Prevent AMD Progression 2:00 pm

Engineering bi-functional IKAR-001 gene therapy to provide synergistic complement targeting, inflammation control, and neuroprotection for GA treatment Utilizing advanced preclinical models to validate therapeutic efficacy and establish proof-of-concept for dual-protein approach Outline the role of PEDF and sCD46 in wet-AMD to emphasis the effectiveness of IKAR-001 gene therapy technologyRead more

day: Conference Day Two

Mastering Gene Therapy Delivery Routes to Optimize Patient Outcomes & Clinical Success 9:00 am

Comparing subretinal, intravitreal, and suprachoroidal delivery approaches to determine the most effective route for specific gene therapy applications Demonstrating advanced surgical techniques through live operative footage to provide hands-on insights into precise subretinal gene therapy injection procedures Evaluating pros and cons of each delivery method to guide evidence-based decision-making for optimal therapeutic outcomesRead more

day: Conference Day One